article thumbnail

Fosun Pharma and IFC to build new drug manufacturing plant in Africa

Pharmaceutical Technology

Fosun Pharma announced that the new facility will improve access to affordable life-saving drugs across west Africa and facilitate the transfer of medical and manufacturing knowledge to the African continent, supporting the long-term growth of the health sector in the region.

article thumbnail

Roche’s head of pharma Bill Anderson heads for exit

pharmaphorum

Anderson will be replaced in the interim as chief executive of Roche Pharma by Thomas Schinecker – currently head of Roche Diagnostics – after he steps down on 1 January. He rose to the position of head of global product strategy at Roche in 2013, before taking the CEO role at Genentech in 2017 and then group head pharma in January 2019.

Pharma 72
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Chiesi expands rare disease portfolio with Amryt Pharma acquisition

pharmaphorum

is to acquire the 2015-established Amryt Pharma Plc. The transaction will be effected by means of a UK scheme of arrangement under Part 26 of the UK Companies Act 2006, subject to approval of Amryt shareholders, sanction by the High Court of Justice of England and Wales, and other customary closings, including regulatory/antitrust approvals.

Pharma 84
article thumbnail

How to get acquisition ready – a seller’s guide to merger and acquisition in pharma

pharmaphorum

M&A is an integral part of the lifecycle of pharma companies and a key strategy to future-proof larger players, driving R&D activities and innovation for a competitive product pipeline. Since the first wave of consolidation started in 1988, there has been a significant concentration of the pharma industry.

Pharma 106
article thumbnail

Payment delays for pharma MSMEs are a significant problem

eMediWrite

Pharma MSMEs might not have the negotiation leverage or other options necessary to properly handle late payments. Challenges posed by payments that are late for pharma MSMEs For pharma MSMEs, late payments present formidable obstacles. The solution to the issue of delayed payments is collaboration.

Pharma 52
article thumbnail

Sweeping changes in leaked EU pharma law draft reignite profit vs access conflict

Pharmaceutical Technology

The EU is planning a sweeping revision of its pharma legislation in March, the largest change in 20 years. The revision process is reviving old conflicts in the pharma industry over fair and affordable access to medicines versus Europe’s status as a competitive home for pharma innovation.

Pharma 64
article thumbnail

Making an Impact During Disease Awareness Days, Weeks, and Months

PM360

Pharma marketers often turn to disease awareness days, weeks, and months to inform campaigns as they strategize for the year ahead. To the pharma marketing industry, these days and months present a clear opportunity to shed light on a particular condition or therapeutic area. Where Should Pharma Marketers Begin?

Media 92